HPV, Chlamydia trachomatis & Neisseria gonorrhoeae, PCR PANEL QUALITATIVE
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About HPV, Chlamydia trachomatis & Neisseria gonorrhoeae, PCR PANEL QUALITATIVE
Over 1 million people are exposed to sexually transmitted infections (STIs) every day, with a majority being caused by HPV, Chlamydia, and Gonorrhea. These infections are often symptomless and brief. But, if left untreated, they can cause lasting complications, affecting the genital organs and fertility.
STIs are more common in women than in men, with infection rates highest among teens and young adults. This raises concerns. But you can prevent HPV, chlamydia, and gonorrhoea infections by getting tested and taking the needed safety steps during sex.
Based on polymerase chain reaction (PCR) technology, the HPV, Chlamydia trachomatis, and Neisseria gonorrhoea PCR Panel Qualitative is a screening method that allows doctors to look for STIs in high-risk individuals. The test detects the presence or absence of a gene in the DNA to identify HPV, Chlamydia trachomatis, and Neisseria gonorrhoea in the sample
What is HPV, Chlamydia trachomatis & Neisseria gonorrhoea, PCR Used For?
The main purpose of HPV, Chlamydia trachomatis & Neisseria gonorrhoea, PCR is
Which tests are included in HPV, Chlamydia trachomatis & Neisseria gonorrhoea, and PCR Test?
The whole panel includes individual PCR tests targeting the respective pathogens. They are
Human PapillomaVirus (HPV) DNA Detection and Genotyping, PCR
This test is used as a screening tool to diagnose cervical cancer. Here, sample cells are examined for the presence of DNA from high-risk HPV types, such as 16 and 18, that are known to cause cancers of the cervix, vagina, and vulva in women. A positive result indicates active viral infection
Chlamydia Trachomatis DNA Detection, PCR
Similar to HPV PCR, this test screens high-risk individuals for chlamydia infection by detecting the presence of bacterial DNA or RNA after amplification in their urine or vaginal swab
Neisseria Gonorrhoea, PCR Qualitative
This test detects the bacterium Neisseria gonorrhoeae in the swab sample collected from the patient's throat, rectum, or genital area
Preparation for Test
No special preparation is required prior to undergoing HPV, Chlamydia trachomatis & Neisseria gonorrhoea PCR test. But ensure that your doctor is aware of the antibiotics you are on
Interpretation of Test Results
The results of HPV, Chlamydia trachomatis, and Neisseria gonorrhoeae PCR qualitative tests are typically given as positive or negative with the interpretations as follows:
Positive result(Abnormal)
A positive report indicates the intended pathogens in the sample provided. Your doctor may then order additional tests for further analysis.
Negative result(Normal)
A negative report means the sample has no said pathogens. Retesting may be helpful in some instances
FAQs on HPV, Chlamydia trachomatis & Neisseria gonorrhoeae, PCR PANEL QUALITATIVE
All sexually active people, including pregnant females, should consider getting tested with HPV, Chlamydia Trachomatis, and Neisseria Gonorrhoea PCR Panel test.
In general, testing is recommended for people who fall into the following risk categories:
- Women 21 years and older
- Sexually active women under 25 years of age
- People with HIV or at risk of HIV
- Men with multiple partners
- People who have sex without a condom
Individuals who have the following symptoms, without fail, must get tested for the HPV, Chlamydia trachomatis, and Neisseria gonorrhoeae
- Painful or burning sensation when peeing
- Discharge from the genitals ( penis in men and vagina and /or cervix in men )
- Unusual vaginal bleeding
- Lumps around genitals or anus
Generally, this test is painless, although some people may experience mild discomfort during sample collection
Yes, it is always better to get tested even if you look healthy because STIs generally are asymptomatic, which often causes them to get missed and left untreated. Unfortunately, this leads to various health complications such as infertility, pelvic inflammatory disease, and sometimes even death
To detect HPV, chlamydia, and gonorrhea co-infection in asymptomatic high-risk individuals
To screen all pregnant women aged 25 years and above who are at risk of contracting STIs

